Short answer · Medically reviewed summary · Last updated: 2026-04-07
Succinic semialdehyde dehydrogenase deficiency (SSADH deficiency) is most commonly referred to by its abbreviation, SSADH deficiency, or as 4-hydroxybutyric aciduria. While historical literature may use various descriptive terms, the medical community now standardizes the name based on the specific enzyme deficiency to ensure clarity in clinical diagnosis and research. What are the common synonyms for SSADH deficiency? In clinical practice, Succinic semialdehyde dehydrogenase deficiency is identified by several names that reflect its biochemical signature.
Succinic semialdehyde dehydrogenase deficiency (SSADH deficiency) is most commonly referred to by its abbreviation, SSADH deficiency, or as 4-hydroxybutyric aciduria. While historical literature may use various descriptive terms, the medical community now standardizes the name based on the specific enzyme deficiency to ensure clarity in clinical diagnosis and research.
In clinical practice, Succinic semialdehyde dehydrogenase deficiency is identified by several names that reflect its biochemical signature. The most frequent synonym is 4-hydroxybutyric aciduria, which refers to the toxic accumulation of 4-hydroxybutyric acid (GHB) in the body. Other terms you may encounter in medical records or older scientific publications include:
The variety of names for Succinic semialdehyde dehydrogenase deficiency exists primarily due to the evolution of medical diagnostics. When the condition was first identified in the 1970s, it was often named after the metabolic byproduct found in the urine (4-hydroxybutyric acid). As genetic testing advanced, researchers identified the specific ALDH5A1 gene mutation, leading to the use of ALDH5A1 deficiency in genetics-focused literature. The shift toward naming the disease after the deficient enzyme—Succinic semialdehyde dehydrogenase deficiency—serves as the current standard, as it precisely describes the physiological mechanism affecting the patient.
Medical professionals and researchers rely on standardized classification systems to ensure accurate tracking and diagnosis of Succinic semialdehyde dehydrogenase deficiency. These systems help bridge the gap between historical naming conventions and current clinical terminology:
When communicating with healthcare providers, using the term Succinic semialdehyde dehydrogenase deficiency is the most effective way to ensure accuracy. If you are searching databases or medical literature, using the abbreviation SSADH deficiency or the gene name ALDH5A1 will often yield the most relevant and up-to-date results. At DiseaseMaps.org, we have observed that 13 community members currently navigating this diagnosis use these terms interchangeably, but standardizing on the full name helps avoid confusion with other metabolic or neurological conditions.
Medical disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.